Search | HMA-EMA Catalogues of real-world data sources and studies

Results (4056)

Multi-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients receiving Bictegravir/ Emtricitabine/Tenofovir alafenamide (B/F/TAF) (BIC-STaR)

France

Germany

Ireland

Italy

Netherlands

Spain

Türkiye

United Kingdom

EU PAS number:

EUPAS22185

First published:

09/02/2018

Last updated 26/07/2024

StudyOngoing

Kesimpta (ofatumumab) pregnancy and infant safety study using real world data

Denmark

Sweden

United States

EU PAS number:

EUPAS106133

First published:

18/09/2023

Last updated 26/07/2024

StudyOngoing

An Observational Study to Describe Women Exposed to Apremilast During Pregnancy and Infant Outcomes During the First Year of Life (20210218)

United States

EU PAS number:

EUPAS107685

First published:

06/12/2023

Last updated 26/07/2024

StudyOngoing

Outcomes of romiplostim for chemotherapy-induced thrombocytopenia (CIT) in solid tumors (20220113)

United States

EU PAS number:

EUPAS1000000067

First published:

05/04/2024

Last updated 25/07/2024

StudyPlanned

DARWIN EU® - Suicidality following exposure to doxycycline

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000280

First published:

25/07/2024

Last updated 25/07/2024

StudyOngoing

University Hospital of Parma

Italy

First published:

21/02/2024

Last updated 25/07/2024

Institution

Hospital/Clinic/Other health care facility

Monasterio Foundation

Italy

First published:

14/03/2024

Last updated 25/07/2024

Institution

Other

University of Bern

Switzerland

First published:

20/03/2024

Last updated 25/07/2024

Institution

Educational Institution

AZ Oostende

Belgium

First published:

01/02/2024

Last updated 25/07/2024

Institution

Hospital/Clinic/Other health care facility

Team Gesundheit GKV Claims data

Germany

First published:

21/11/2022

Last updated 25/07/2024

Data source

Administrative healthcare claims

AZ Oostende (previously: AZ Damiaan)

Belgium

First published:

01/02/2024

Last updated 25/07/2024

Data source

Cancer registryDeath registryHospital inpatient recordsOther

A prospective, non-interventional study (NIS) with trastuzumab deruxtecan for patients with HER2-low expressing unresectable and/or metastatic breast cancer accompanied by a disease registry of patients treated with conventional chemotherapy (DESTINY Breast Respond HER2-low Europe)

Austria

Belgium

Denmark

France

Italy

Netherlands

Norway

Portugal

Spain

Sweden

Switzerland

EU PAS number:

EUPAS1000000277

First published:

23/07/2024

Last updated 24/07/2024

StudyOngoing

The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)

Netherlands

First published:

07/01/2022

Last updated 24/07/2024

Institution

Laboratory/Research/Testing facilityENCePP partner

International PNH Interest Group (IPIG)

United States

First published:

24/07/2024

Last updated 24/07/2024

Institution

Not-for-profit

Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont (UPO)

Italy

First published:

07/11/2016

Last updated 24/07/2024

Institution

Educational InstitutionENCePP partner

Budget impact analysis of discontinuing Tyrosin Kinase Inhibitors in patients with chronic myeloid leukemia achieving a complete molecular response by using probabilistic Markov approach (ECOSTIM)

France

EU PAS number:

EUPAS18568

First published:

21/04/2017

Last updated 24/07/2024

StudyFinalised

Prognostic value of Continuous Glucose Monitoring metrics for microvascular and macrovascular complications in diabetes using Freestyle Libre® system records and SNDS French claims database linkage (FACULTY)

France

EU PAS number:

EUPAS1000000188

First published:

24/07/2024

Last updated 24/07/2024

StudyPlanned

A regulatory requirement non-interventional study to monitor the safety and effectiveness of Spesolimab in Korean patients with flares with generalized pustular psoriasis

Korea, Republic of

EU PAS number:

EUPAS1000000278

First published:

24/07/2024

Last updated 24/07/2024

StudyPlanned

Economic evaluation of robot-assisted laparoscopic radical prostatectomy vs conventional laparoscopic radical prostatectomy and open retropubic radical prostatectomy in prostate cancer: a real-life study based on the French National Healthcare Data System (SNDS). (ECOREPAR)

France

EU PAS number:

EUPAS33290

First published:

29/01/2020

Last updated 24/07/2024

StudyFinalised

Impact of cardiovascular comorbidities on the effectiveness of bevacizumab in elderly patients with metastatic colorectal cancer (IRAZU)

France

EU PAS number:

EUPAS32748

First published:

12/12/2019

Last updated 24/07/2024

StudyOngoing

Cancer risk estimation study program in patients treated with insulin in France (GROC)

France

EU PAS number:

EUPAS3105

First published:

30/10/2012

Last updated 24/07/2024

StudyFinalised

Economic evaluation of Prostatic Urethral Lift (Urolift) (ECOLIFT)

France

EU PAS number:

EUPAS33766

First published:

20/02/2020

Last updated 24/07/2024

StudyOngoing

Incidence, prevalence and burden of Dry Eye diseAse in France (IDEA)

France

EU PAS number:

EUPAS29618

First published:

03/05/2019

Last updated 24/07/2024

StudyFinalised

EPIHAM: Drug-induced liver injury leading to hospital admission: a study in national healthcare insurance databases

France

EU PAS number:

EUPAS7549

First published:

29/09/2014

Last updated 24/07/2024

StudyFinalised

Alert generation using the case-population approach in the French claims databases (ALCAPONE)

France

EU PAS number:

EUPAS13031

First published:

06/04/2016

Last updated 24/07/2024

StudyFinalised

Therapeutic strategy in metastatic castration-resistant prostate cancer: target population and changes between 2012 and 2014. Two sequential cohorts within the French nation-wide claims and hospital database (CAMERRA)

France

EU PAS number:

EUPAS21285

First published:

10/04/2018

Last updated 24/07/2024

StudyFinalised

FUJI study: Follow-Up of Jevtana® in real lIfe

France

EU PAS number:

EUPAS10391

First published:

15/09/2015

Last updated 24/07/2024

StudyFinalised

Resistant Depression in France, description from the nationwide claims and hospitalization database (DIORAMA)

France

EU PAS number:

EUPAS20778

First published:

13/10/2017

Last updated 24/07/2024

StudyFinalised

Non-Interventional retrospective longitudinal study in the United Kingdom and France to investigate the therapeutic strategies after discontinuation of valproate and related substances in clinical practice (VALSE study - VALNAC09344)

France

United Kingdom

EU PAS number:

EUPAS37438

First published:

30/09/2020

Last updated 24/07/2024

StudyFinalised

Nurses Internal Contamination by Antineoplastic Drugs (CACIES)

France

EU PAS number:

EUPAS19729

First published:

31/07/2017

Last updated 24/07/2024

StudyFinalised

A regulatory non-interventional study to monitor the safety and efficacy of JARDIANCE® (Empagliflozin 10 mg) in Korean patients with Chronic Kidney Disease (CKD)

Korea, Republic of

EU PAS number:

EUPAS107293

First published:

24/10/2023

Last updated 24/07/2024

StudyOngoing

DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

Germany

Netherlands

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000254

First published:

10/07/2024

Last updated 23/07/2024

StudyOngoing

PHARMO Data Network

Netherlands

First published:

01/02/2024

Last updated 23/07/2024

Data source

Hospital discharge recordsOtherPharmacy dispensing recordsPrimary care medical records

Effectiveness evaluation of the local additional risk minimisation measures for STAMARIL® in the United Kingdom: a survey for healthcare professionals and vaccinees

United Kingdom

EU PAS number:

EUPAS50782

First published:

22/02/2023

Last updated 23/07/2024

StudyFinalised

Daiichi-Sankyo Europe GmbH

Germany

First published:

23/07/2024

Last updated 23/07/2024

Institution

Pharmaceutical company

Comparative assessment of venous thromboembolism and other risks among patients with rheumatoid arthritis treated with baricitinib versus tumor necrosis factor inhibitors - French part of the study program (Safety Outcomes in Patients Treated for RA)

France

EU PAS number:

EUPAS34204

First published:

19/03/2020

Last updated 23/07/2024

StudyOngoing

Dual antiplatelet therapy for prolonged secondary prevention of acute coronary events (DEEPSPACE)

France

EU PAS number:

EUPAS29177

First published:

15/07/2019

Last updated 23/07/2024

StudyOngoing

Programme d’évaluation de la vaccination COVID-19 : Risque d’effets indésirables d’intérêt des différents vaccins et comparaison du bénéfice-risque des vaccins (EVACOV-RISC)

France

EU PAS number:

EUPAS103839

First published:

08/03/2023

Last updated 23/07/2024

StudyPlanned

Assessment of The High risk and unmEt Need in patients with Coronary Artery Disease and type 2 diabetes in France (ATHENA-F)

France

EU PAS number:

EUPAS27402

First published:

07/01/2019

Last updated 23/07/2024

StudyFinalised

Use of Selincro® and impact on usual practice (USE-PACT)

France

EU PAS number:

EUPAS11854

First published:

15/12/2015

Last updated 23/07/2024

StudyFinalised

Search all content

Filter options

Results (4056)